Patents by Inventor Rick C. Betori

Rick C. Betori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED CHROMANES, ANALOGS THEREOF, AND METHODS OF USE AND SYNTHESIS
    Publication number: 20230339879
    Abstract: Disclosed are chromane compounds, analogs thereof, and methods of their synthesis and use. The compounds may be synthesized by methods involving reductive annulations of arylidene malonates with unsaturated electrophiles using photoredox/Lewis acid cooperative catalysis. The compounds may be formulated in a pharmaceutical composition for treating one of the aforementioned diseases or disorders.
    Type: Application
    Filed: March 21, 2023
    Publication date: October 26, 2023
    Inventors: Karl A. Scheidt, Rick C. Betori, Benjamin R. McDonald
  • Substituted chromanes, analogs thereof, and methods of use and synthesis
    Patent number: 11639340
    Abstract: Disclosed are chromane compounds, analogs thereof, and methods of their synthesis and use. The compounds may be synthesized by methods involving reductive annulations of arylidene malonates with unsaturated electrophiles using photoredox/Lewis acid cooperative catalysis. The compounds may be formulated in a pharmaceutical composition for treating one of the aforementioned diseases or disorders.
    Type: Grant
    Filed: July 8, 2020
    Date of Patent: May 2, 2023
    Assignee: NORTHWESTERN UNIVERSITY
    Inventors: Karl A. Scheidt, Rick C. Betori, Benjamin R. McDonald
  • 3-Methylideneoxan-4-One Compounds and Substituted Derivates Thereof as Inhibitors of Telomerase
    Publication number: 20230115088
    Abstract: Disclosed are 3-methylideneoxan-4-one compounds, derivatives thereof, and methods of their synthesis and methods of their use in treating a disease or disorder in a subject in need thereof, such as diseases and disorders that are associated with telomerase activity such as cancer. The disclosed compounds may be formulated in a pharmaceutical composition for treating diseases and disorders that are associated with telomerase activity such as cancer.
    Type: Application
    Filed: October 13, 2022
    Publication date: April 13, 2023
    Inventors: Karl A. Scheidt, Rick C. Betori
  • 3-methylideneoxan-4-one compounds and substituted derivatives thereof as inhibitors of telomerase
    Patent number: 11518750
    Abstract: Disclosed are 3-methylideneoxan-4-one compounds, derivatives thereof, and methods of their synthesis and methods of their use in treating a disease or disorder in a subject in need thereof, such as diseases and disorders that are associated with telomerase activity such as cancer. The disclosed compounds may be formulated in a pharmaceutical composition for treating diseases and disorders that are associated with telomerase activity such as cancer.
    Type: Grant
    Filed: August 6, 2020
    Date of Patent: December 6, 2022
    Assignee: NORTHWESTERN UNIVERSITY
    Inventors: Karl A. Scheidt, Rick C. Betori
  • 3-METHYLIDENEOXAN-4-ONE COMPOUNDS AND SUBSTITUTED DERIVATIVES THEREOF AS INHIBITORS OF TELOMERASE
    Publication number: 20210070725
    Abstract: Disclosed are 3-methylideneoxan-4-one compounds, derivatives thereof, and methods of their synthesis and methods of their use in treating a disease or disorder in a subject in need thereof, such as diseases and disorders that are associated with telomerase activity such as cancer. The disclosed compounds may be formulated in a pharmaceutical composition for treating diseases and disorders that are associated with telomerase activity such as cancer.
    Type: Application
    Filed: August 6, 2020
    Publication date: March 11, 2021
    Applicant: NORTHWESTERN UNIVERSITY
    Inventors: Karl A. Scheidt, Rick C. Betori
  • SUBSTITUTED CHROMANES, ANALOGS THEREOF, AND METHODS OF USE AND SYNTHESIS
    Publication number: 20210009547
    Abstract: Disclosed are chromane compounds, analogs thereof, and methods of their synthesis and use. The compounds may be synthesized by methods involving reductive annulations of arylidene malonates with unsaturated electrophiles using photoredox/Lewis acid cooperative catalysis. The compounds may be formulated in a pharmaceutical composition for treating one of the aforementioned diseases or disorders.
    Type: Application
    Filed: July 8, 2020
    Publication date: January 14, 2021
    Applicant: NORTHWESTERN UNIVERSITY
    Inventors: Karl A. Scheidt, Rick C. Betori, Benjamin R. McDonald